header("Access-Control-Allow-Origin: *"); ?>
The present invention relates to a composition comprising an aqueous phase, a polyene antifungal and lipid nanoparticles which are dispersed in the […]
The present invention arises from a formulation study in order to define the best excipients including buffer, surfactant, sugar and amino acid to […]
Antimicrobial resistance is a global problem, rendering conventional treatments less effective and requiring innovative strategies to combat this […]
The present invention relates to the treatment of infectious diseases. In this study, the inventors identified the potential protective mechanisms […]
Tumour-specific molecular targets and alternative therapeutic strategies for triplenegative breast cancer (TNBC) are urgently needed. The protease […]
In ovarian carcinoma, Müllerian Inhibiting Substance (MIS) type II receptor (MISRII) and the MIS/MISRII signaling pathway are potential therapeutic […]
The present invention relates to a method for treating an infection, particularly HCMV infection. To date, there are very few reports on the role of […]
[…]
Chronic obstructive pulmonary disease (COPD) remains a major cause of morbidity and mortality worldwide. Acute exacerbation of COPD (AE-COPD) in […]
The present invention relates to the treatment of idiopathic pulmonary fibrosis. Today, there is no cure for IPF. The inventors showed that EPAC1 […]